argenx SE (ARGX)
873.70
-2.06
(-0.23%)
USD |
NASDAQ |
Oct 23, 16:00
873.46
-0.24
(-0.03%)
After-Hours: 20:00
argenx Enterprise Value : 54.00B for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 54.00B |
| October 22, 2026 | 54.13B |
| October 21, 2026 | 55.01B |
| October 20, 2026 | 53.75B |
| October 19, 2026 | 51.02B |
| October 16, 2026 | 50.62B |
| October 15, 2026 | 52.30B |
| October 14, 2026 | 50.57B |
| October 13, 2026 | 49.60B |
| October 12, 2026 | 50.20B |
| October 09, 2026 | 50.99B |
| October 08, 2026 | 50.59B |
| October 07, 2026 | 57.39B |
| October 06, 2026 | 57.52B |
| October 05, 2026 | 56.42B |
| October 02, 2026 | 56.82B |
| October 01, 2026 | 57.86B |
| September 30, 2026 | 59.27B |
| September 29, 2026 | 60.00B |
| September 28, 2026 | 60.10B |
| September 25, 2026 | 59.31B |
| September 24, 2026 | 59.48B |
| September 23, 2026 | 58.46B |
| September 22, 2026 | 59.57B |
| September 21, 2026 | 61.09B |
| Date | Value |
|---|---|
| September 18, 2026 | 61.22B |
| September 17, 2026 | 61.55B |
| September 16, 2026 | 60.87B |
| September 15, 2026 | 60.56B |
| September 14, 2026 | 61.23B |
| September 11, 2026 | 60.85B |
| September 10, 2026 | 60.83B |
| September 09, 2026 | 61.96B |
| September 08, 2026 | 62.25B |
| September 04, 2026 | 63.87B |
| September 03, 2026 | 65.12B |
| September 02, 2026 | 65.24B |
| September 01, 2026 | 63.58B |
| August 31, 2026 | 63.77B |
| August 28, 2026 | 63.25B |
| August 27, 2026 | 65.46B |
| August 26, 2026 | 64.73B |
| August 25, 2026 | 63.02B |
| August 24, 2026 | 62.50B |
| August 21, 2026 | 64.28B |
| August 20, 2026 | 64.17B |
| August 19, 2026 | 63.85B |
| August 18, 2026 | 61.38B |
| August 17, 2026 | 61.06B |
| August 14, 2026 | 52.61B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Autolus Therapeutics Plc | 574.58M |
| Cellectis SA | 36.12M |
| Akari Therapeutics Plc | 7.336M |
| Forte Biosciences, Inc. | 1.378B |
| DBV Technologies SA | 364.13M |
Enterprise Value Related Metrics
| Earnings Yield | 3.00% |
| Operating Earnings Yield | 2.64% |
| Normalized Earnings Yield | 3.003 |